Calithera Biosciences, Inc.
Heterocyclic glutaminase inhibitors
Last updated:
Abstract:
The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention.
Status:
Grant
Type:
Utility
Filling date:
15 Nov 2013
Issue date:
6 Oct 2020